Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
DERM
↓ PDF (Pro)Journey Medical Corporation Common Stock
HealthcareDrug Manufacturers - Specialty & GenericUnited StatesNASDAQ
$5.26
+1.54%today
MKT CAP
$144M
+1.0% · 1Y
Earnings History
+24.2%
-52.4%
-140.0%
+30.4%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$5.26
Low
$12.00
Analyst Mean
$13.50
High
$16.00
4 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-83.3x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-8.8%
5y Revenue CAGR-5.7%
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership32.6%
Institutional Ownership56.3%
Short % of Float24.86%
Days to Cover10.4d
1 Week-2.7%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| MARAOUI CLAUDE | Chief Executive Officer | Stock | 49,277 | $0.00 | $0.00M | 2026-04-22 |
| BENESCH JOSEPH | Chief Financial Officer | Stock | 28,907 | $0.00 | $0.00M | 2026-04-22 |
| ALLOUSH RAMSEY | Chief Operating Officer | Stock | 46,863 | $0.00 | $0.00M | 2026-04-22 |
| MARAOUI CLAUDE | Chief Executive Officer | Conversion | 1,250,000 | $0.06 | $0.08M | 2025-08-25 |
| ROSENWALD LINDSAY A | Director | Stock | 50,000 | $0.00 | $0.00M | 2025-08-05 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Wasatch Advisors LP | institution | 9.99% | $0.01B | +62.08% | 2026-03-31 |
| Tang Capital Management, LLC | institution | 8.69% | $0.01B | +0.00% | 2025-12-31 |
| Opaleye Management Inc. | institution | 4.57% | $0.01B | +0.41% | 2025-12-31 |
| J. Goldman & Co., L.P. | institution | 3.74% | $0.00B | +100.00% | 2025-12-31 |
| Vanguard Group Inc | institution | 3.58% | $0.00B | +24.21% | 2025-12-31 |
| WASATCH FUNDS TRUST-Wasatch Micro Cap Value Fund | fund | 3.41% | $0.00B | +24.72% | 2025-12-31 |
| Blackrock Inc. | institution | 3.37% | $0.00B | +13.70% | 2025-12-31 |
| Millennium Management Llc | institution | 2.14% | $0.00B | +100.00% | 2025-12-31 |
| Pale Fire Capital SE | institution | 2.08% | $0.00B | +94.53% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.02% | $0.00B | +44.22% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 ETF | fund | 1.98% | $0.00B | +31.82% | 2026-03-31 |
| Summit Financial, LLC | institution | 1.83% | $0.00B | +2.79% | 2025-12-31 |
| Essex Investment Management Co LLC | institution | 1.62% | $0.00B | -2.27% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 Growth ETF | fund | 0.75% | $0.00B | +30.88% | 2026-03-31 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | fund | 0.66% | $0.00B | -1.44% | 2026-01-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 0.61% | $0.00B | -4.94% | 2025-12-31 |
| 1290 Funds-1290 Essex Small Cap Growth Fund | fund | 0.37% | $0.00B | +2.85% | 2026-01-31 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | fund | 0.34% | $0.00B | -0.36% | 2026-02-28 |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | fund | 0.33% | $0.00B | +18.69% | 2026-02-28 |
| iShares Trust-iShares Micro-Cap ETF | fund | 0.24% | $0.00B | +37.88% | 2026-03-31 |
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| BIOA | $820M | - | - | - | - | -27.1% | 0% | 2.04 | 0.00% |
| ETON | $833M | 60 | - | 16.4 | - | - | - | - | 0.00% |
| PCRX | $937M | 58 | 193.0 | 7.0 | - | - | - | - | 0.00% |
| CRON | $990M | 5 | - | - | - | - | - | - | 0.00% |
| AMPH | $1.1B | 100 | 11.8 | 6.9 | - | - | - | - | 0.00% |
| XERS | $1.1B | 60 | 94.7 | 17.0 | - | - | - | - | 0.00% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for DERM.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.